What is Humanin? What it does, benefits and what the evidence shows

Humanin is a 24-amino-acid peptide encoded in the mitochondrial genome that protects cells from stress-induced death in lab experiments. It was found in a screen for factors that protect nerve cells from Alzheimer's-related toxicity, and it has since been tested in cells, worms and rodents for brain, heart, blood sugar and aging effects. In people, the research so far measures how much humanin is in the blood, not what happens when someone takes it. We found no approval and no human treatment trial.

What Humanin is and how it works

In 2001 a research group screened for genes that could protect neurons from death caused by familial Alzheimer's disease genes and amyloid beta. The gene they found encodes a short polypeptide, which they named Humanin, and which was secreted from the cells that made it (Hashimoto et al., PNAS, 2001). It is a peptide of 24 amino acids, and in 2003 a Nature paper showed it binds Bax, a protein that drives cell death, and prevents Bax from moving to mitochondria. The same paper noted that the mitochondrial genome contains an identical open reading frame, and the authors speculated that humanin arose from mitochondria and transferred to the nuclear genome (Guo et al., Nature, 2003).

Humanin is the best-known member of a family of peptides encoded by short open reading frames in mitochondrial DNA. A 2022 review counts eight published so far: humanin, MOTS-c and six small humanin-like peptides (Miller et al., Journal of Clinical Investigation, 2022). MOTS-c is covered in our MOTS-c guide, and SS-31 is a separate mitochondria-targeted peptide.

Much of the animal work uses HNG (also written S14G-humanin), a version in which one amino acid is swapped. In mouse memory experiments it was described as about 1,000 times more potent than natural humanin in cell tests (Tajima et al., Journal of Neuroscience Research, 2005). When you read that "humanin" protected something in a mouse, check whether the study used the natural peptide or this analog; the evidence for one is not evidence for the other.

What people use it for

What the research actually shows

Brain protection

The original findings were in cultured neurons. The first mouse test of the analog HNG found that it prevented memory impairment caused by an amyloid fragment in a Y-maze test and preserved cholinergic neurons in the basal forebrain (Tajima et al., 2005). That is a chemically induced amnesia model, not a model of the slow disease in people. A later study reported that humanin improved cognition in aged mice and protected cultured human cells, and that a specific variant in the humanin-coding region of mitochondrial DNA was linked to lower blood humanin and to faster cognitive aging in a large cohort of older adults (Yen et al., 2018). A genetic association like that suggests humanin matters biologically. It does not show that adding more of it helps.

Blood sugar and metabolism

In rodent clamp experiments, humanin and potent analogs improved insulin sensitivity, and the effect involved STAT3 signaling in the hypothalamus. One analog lowered blood glucose in diabetic rats. In the same paper, circulating humanin fell with age in humans and mice (Muzumdar et al., 2009). The authors suggested that the decline could contribute to age-related disease. That is a hypothesis, and the human part of the paper measures levels rather than testing a treatment.

Heart

In mice with a blocked and then reopened heart artery, HNG reduced infarct size and preserved heart function (Muzumdar et al., 2010). The authors said it "may represent" a new agent for heart attack, which is the honest limit of the claim. In 40 people undergoing coronary testing, those with poor coronary endothelial function had lower blood humanin levels (about 1.3 versus 2.2 ng/ml) than those with normal function (Widmer et al., American Journal of Physiology, Heart and Circulatory Physiology, 2013). It is a small cross-sectional study, so it cannot say whether low humanin causes the dysfunction.

Lifespan and healthspan

The 2020 Aging paper is where most longevity claims come from. Overexpressing humanin extended lifespan in the roundworm C. elegans, and the effect depended on a longevity gene (daf-16/FOXO). Humanin-transgenic mice showed extra protection against toxic insults, and middle-aged mice given the analog HNG had better metabolic healthspan measures and lower inflammatory markers. The paper also reports that humanin levels are much higher in children of centenarians than in matched controls, and lower in people with Alzheimer's disease and in MELAS, a mitochondrial disease (Yen et al., 2020). The lifespan and healthspan findings are in worms and mice, and the human findings are correlations.

Human treatment data

There are none that we found. The ClinicalTrials.gov records that mention humanin, when we searched on September 29, 2026, were either observational studies of blood levels or trials of something else (an anesthesia comparison and an exercise program, for example). We found no registered trial that gives humanin or an analog to patients. The research on people covers blood-level associations. In a 24-month study of 83 hemodialysis patients, adding humanin levels improved the accuracy of cardiovascular risk models, and both low and high levels were linked to more cardiovascular events (Bolignano et al., Cardiorenal Medicine, 2026). That curved pattern is a useful caution: in that group, more humanin did not simply mean better outcomes.

Side effects and risks

• No human safety data. Nobody has published a trial giving humanin to people, so its side effects in humans are unknown.
• Cancer questions are unresolved. A 2019 review of humanin as a therapeutic target says the controversy over its role in cancer progression and chemoresistance should be addressed before therapies are developed (Zuccato et al., Expert Opinion on Therapeutic Targets, 2019). We did not find a study that settles it in either direction.
• Analog versus natural peptide. Much of the best-looking animal data uses HNG, not natural humanin, so the safety and benefit picture for a vial labelled "humanin" is even less certain.
• Narrow models. The animal results come from specific induced models, such as chemically induced amnesia or an induced heart attack, not from naturally occurring human disease.
• Regulatory status. We found no approved product: a drug-name search of DailyMed and a search of the openFDA Drugs@FDA database returned nothing for humanin, and it does not appear on FDA's page of bulk drug substances with significant safety risks (FDA, page current as of April 22, 2026). We did not search other regulators. Absence from a list means it hasn't been evaluated there, not that it is safe.

What the lab tests show

As of September 29, 2026, VendorVerify's database has no lab results for humanin that we can count yet. That doesn't mean vials are good or bad; it means we can't say. If you have had a humanin vial tested, submitting the report is the fastest way to change that.

Because we don't have enough lab data on this compound to rank vendors for it, here are the highest-ranked vendors across all compounds right now. A vendor's overall record is a signal, not a guarantee for a compound they have never had tested.

Buying smarter

With no compound-specific data, lean on the general checks. Look at each vendor's full record and how many reports sit behind the score, and treat a vendor-posted COA as a starting point (how to read a peptide COA, fake peptide COAs). Ask which form is being sold: natural humanin or a modified analog such as HNG, since the research differs. A report that confirms identity, purity and quantity on your own vial is worth paying for; how to get a peptide tested walks through it, and endotoxin in research peptides covers when to add that test.

If a report comes back with a fail, stop using that batch, tell anyone who bought from the same run, bring the report to the vendor, and submit it to VendorVerify. Readers looking at mitochondrial peptides also read about MOTS-c, SS-31 and FOXO4-DRI; the peptide hub lists every compound we track.

Database figures are from VendorVerify as of September 29, 2026. This isn't medical advice; humanin has no approval anywhere we searched and no human treatment trial we could find.